기관지천식에서 Prostaglandin D_2의 역할

키워드

참고문헌 (47)

1. Fanta CH, "Asthma", N Engl J Med, 360, pp.1002~1014 (2009)
2. Galli SJ, "The development of allergic inflammation", Nature, 454, pp.445~454 (2008)
3. Boyce JA, "Eicosanoids in asthma, allergic inflammation, and host defense", Curr Mol Med, 8, pp.335~349 (2008)
4. Dahlén SE, "Monitoring mast cell activation by prostaglandin D2 in vivo", Thorax, 59, pp.453~455 (2004)
5. Bochenek G, "Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma", Thorax, 59, pp.459~464 (2004)
6. O'Sullivan S, "Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions", Clin Exp Allergy, 28, pp.1332~1339 (1998)
7. Murray JJ, "Release of prostaglandin D2 into human airways during acute antigen challenge", N Engl J Med, 315, pp.800~804 (1986)
8. Oguma T, "Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma", Allergol Int, 57, pp.307~312 (2008)
9. Singh D, "Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459", Eur Respir J (2012)
10. Funk CD, "Prostaglandins and leukotrienes: advances in eicosanoid biology", Science, 294, pp.1871~187 (2001)
11. Urade Y, "Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence", Prostaglandins Other Lipid Mediat, 68, pp.375~382 (2002)
12. Seibert K, "(5Z,13E)-(15S)-9 alpha,11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta- prostaglandin F2): formation and metabolism by human lung and contractile effects on human bronchial smooth muscle", Proc Natl Acad Sci U S A, 84, pp.256~260 (1987)
13. Rovati GE, "Dual COXIB", TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular risk, 2010, pp.31, 102~107
14. McAdam BF, "Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2", Proc Natl Acad Sci U S A, 96, pp.272~277 (1999)
15. Murakami M, "IgE-dependent activation of cytokine-primed mouse cultured mast cells induces a delayed phase of prostaglandin D2 generation via prostaglandin endoperoxide synthase-2", J Immunol, 155, pp.4445~4453 (1995)
16. Choi JH, "PGD2 biosynthesis in several human mast cell models is catalyzed by cycloxygenase-1", Annual meeting of European Respiratory Society (2011)
17. Daham K, "Effects of celecoxib on major prostaglandins in asthma", Clin Exp Allergy, 41, pp.36~45 (2011)
18. Obata T, "Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells", Clin Exp Allergy, 29, pp.1129~1135 (1999)
19. Hirai H, "Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2", J Exp Med, 193, pp.255~261 (2001)
20. Monneret G, "Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor", Blood, 98, pp.1942~1948 (2001)
21. Whittle BJ, "Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue", Prostaglandins, 25, pp.205~223 (1983)
22. Wright DH, "Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist", Br J Pharmacol, 123, pp.1317~1324 (1998)
23. Sawyer N, "Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2", Br J Pharmacol, 137, pp.1163~1172 (2002)
24. Gervais FG, "Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP", J Allergy Clin Immunol, 108, pp.982~988 (2001)
25. Angeli V, "Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses", J Immunol, 172, pp.3822~3829 (2004)
26. Magnussen H, "Effects of a thromboxane-receptor antagonist, BAY u 3405, on prostaglandin D2- and exercise-induced bronchoconstriction", J Allergy Clin Immunol, 89, pp.1119~1126 (1992)
27. Liu MC, "Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes", Am Rev Respir Dis, 144, pp.51~58 (1991)
28. Balzar S, "Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program", Am J Respir Crit Care Med, 183, pp.299~309 (2011)
29. O'Sullivan S, "Evidence for mast cell activation during exercise-induced bronchoconstriction", Eur Respir J, 12, pp.345~350 (1998)
30. O'Sullivan S, "Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta- prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction", J Allergy Clin Immunol, 98, pp.421~432 (1996)
31. Fujitani Y, "Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice", J Immunol, 168, pp.443~449 (2002)
32. Honda K, "Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage- derived chemokine", J Exp Med, 198, pp.533~443 (2003)
33. Matsuoka T, "Prostaglandin D2 as a mediator of allergic asthma", Science, 287, pp.2013~2017 (2000)
34. Arimura A, "Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751", J Pharmacol Exp Ther, 298, pp.411~419 (2001)
35. Hammad H, "Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells", J Exp Med, 204, pp.357~367 (2007)
36. Shiraishi Y, "Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor", J Pharmacol Exp Ther, 312, pp.954~960 (2005)
37. Uller L, "Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation", Respir Res, 8, pp.16~ (2007)
38. Noguchi E, "New polymorphisms of haematopoietic prostaglandin D synthase and human prostanoid DP receptor genes", Clin Exp Allergy, 32, pp.93~96 (2002)
39. Li J, "Lack of association between three promoter polymorphisms of PTGDR gene and asthma in a Chinese Han population", Int J Immunogenet, 34, pp.353~357 (2007)
40. Oguma T, "Role of prostanoid DP receptor variants in susceptibility to asthma", N Engl J Med, 351, pp.1752~1763 (2004)
41. Tsai YJ, "Genetics of Asthma in Latino Americans Study; Study of African Americans, Asthma, Genes and Environments Investigators. The PTGDR gene is not associated with asthma in 3 ethnically diverse populations", J Allergy Clin Immunol, 118, pp.1242~1248 (2006)
42. Zhu G, "Association of PTGDR gene polymorphisms with asthma in two Caucasian populations", Genes Immun, 8, pp.398~403 (2007)
43. Kim SH, "Association between polymorphisms inprostanoid receptor genes and aspirin-intolerant asthma", Pharmacogenet Genomics, 17, pp.295~304 (2007)
44. Isidoro-García M, "PTGDR gene in asthma: a functional, genetic, and epigenetic study", Allergy, 66, pp.1553~1562 (2011)
45. Huang JL, "Sequence variants of the gene encoding chemoattractant receptor expressed on Th2 cells (CRTH2) are associated with asthma and differentially influence mRNA stability", Hum Mol Genet, 13, pp.2691~2697 (2004)
46. Maeda Y, "Genetic impact of functional single nucleotide polymorphisms in the 3'-UTR region of the chemoattractant receptor expressed on Th2 cells (CRTH2) gene on asthma and atopy in a Japanese population", Int Arch Allergy Immunol, 142, pp.51~58 (2007)
47. Palikhe NS, "Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease", Allergy, 65, pp.338~346 (2010)

관련 논문AI추천